M
Marcel E. Curlin
Researcher at Centers for Disease Control and Prevention
Publications - 45
Citations - 2162
Marcel E. Curlin is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Men who have sex with men & Pre-exposure prophylaxis. The author has an hindex of 15, co-authored 33 publications receiving 1633 citations. Previous affiliations of Marcel E. Curlin include Thailand Ministry of Public Health & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
Kachit Choopanya,Michael Martin,Michael Martin,Pravan Suntharasamai,Udomsak Sangkum,Philip A. Mock,Manoj Leethochawalit,Sithisat Chiamwongpaet,Praphan Kitisin,Pitinan Natrujirote,Somyot Kittimunkong,Rutt Chuachoowong,Roman Gvetadze,Janet M. McNicholl,Janet M. McNicholl,Lynn A. Paxton,Marcel E. Curlin,Marcel E. Curlin,Craig W. Hendrix,Suphak Vanichseni +19 more
TL;DR: Daily oral tenofovir reduced the risk of HIV infection in people who inject drugs and can now be considered for use as part of an HIV prevention package for people who injecting drugs.
Journal ArticleDOI
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
Timothy A. Bates,Savannah K. McBride,Hans C. Leier,Gaelen Guzman,Zoe L Lyski,Devin Schoen,Bradie Winders,Joon-Yong Lee,D. X. Lee,William B. Messer,Marcel E. Curlin,Fikadu G. Tafesse +11 more
TL;DR: It is found that human immune sera after breakthrough infection and vaccination after natural infection broadly neutralize SARS-CoV-2 (severe acute respiratory coronavirus 2) variants to a similar degree.
Journal ArticleDOI
Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.
Yen T. Duong,Reshma Kassanjee,Alex Welte,Meade Morgan,Anindya K. De,Trudy Dobbs,Erin K. Rottinghaus,John N. Nkengasong,Marcel E. Curlin,Chonticha Kittinunvorakoon,Boonyos Raengsakulrach,Michael Martin,Kachit Choopanya,Suphak Vanichseni,Yan Jiang,Maofeng Qiu,Haiying Yu,Yan Hao,Neha Shah,Linh Vi Le,Andrea A. Kim,Tuan Anh Nguyen,William Ampofo,Bharat Parekh +23 more
TL;DR: Determination of revised parameters for estimation of HIV-1 incidence should facilitate application of the LAg-Avidity EIA for worldwide use.
Journal ArticleDOI
The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs
Michael Martin,Suphak Vanichseni,Pravan Suntharasamai,Udomsak Sangkum,Philip A. Mock,Philip A. Mock,Manoj Leethochawalit,Sithisat Chiamwongpaet,Marcel E. Curlin,Marcel E. Curlin,Supawadee Na-pompet,Anchalee Warapronmongkholkul,Somyot Kittimunkong,Roman Gvetadze,Janet M. McNicholl,Lynn A. Paxton,Kachit Choopanya +16 more
TL;DR: In this HIV PrEP trial among people who inject drugs, improved adherence to daily tenofovir was associated with a lower risk of HIV infection, consistent with trials among MSM and HIV-discordant heterosexual couples and suggests that HIV Pr EP can provide a high level of protection from HIV infection.
Journal ArticleDOI
Renal Function of Participants in the Bangkok Tenofovir Study—Thailand, 2005–2012
Michael Martin,Suphak Vanichseni,Pravan Suntharasamai,Udomsak Sangkum,Philip A. Mock,Roman Gvetadze,Marcel E. Curlin,Manoj Leethochawalit,Sithisat Chiamwongpaet,Thitima Cherdtrakulkiat,Rapeepan Anekvorapong,Wanna Leelawiwat,Nartlada Chantharojwong,Janet M. McNicholl,Lynn A. Paxton,Somyot Kittimunkong,Kachit Choopanya +16 more
TL;DR: Small but significant decreases in cross-sectional measures of creatinine clearance and GFR in the tenofovir group compared with the placebo group and modest differences in downward trends in longitudinal analysis using the Cockcroft-Gault and CKD-EPI equations are found.